Citation Impact

Citing Papers

Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases
2011 Standout
Ribosomal S6 Kinase 2 Is a Key Regulator in Tumor Promoter–Induced Cell Transformation
2007
Astrocytes: biology and pathology
2009 Standout
Suppression of cell transformation and induction of apoptosis by caffeic acid phenethyl ester
2001
Mitogen- and Stress-Activated Kinase 1–Mediated Histone H3 Phosphorylation Is Crucial for Cell Transformation
2008
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
1998 Standout
Inhibition of Activator Protein 1 Activity and Neoplastic Transformation by Aspirin
1997
Cancer chemoprevention with dietary phytochemicals
2003 Standout
The tor pathway: a target for cancer therapy
2004 Standout
Signal transduction pathways: targets for chemoprevention of skin cancer
2000
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Degradation of a Calcium Influx Factor (CIF) Can Be Blocked by Phosphatase Inhibitors or Chelation of Ca2+
1995 StandoutNobel
Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
1993
Free radicals, metals and antioxidants in oxidative stress-induced cancer
2006 Standout
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate–induced invasion in mouse keratinocytes
1997
Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells
2008
A New Twist in TCR Diversity Revealed by a Forbidden αβ TCR
2007 StandoutNobel
AP-1: a double-edged sword in tumorigenesis
2003 Standout
Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms
2004
Classification of papillomaviruses
2004 StandoutNobel
Marine natural products
1990 Standout
p53 and c-Jun Functionally Synergize in the Regulation of the DNA Repair Gene hMSH2 in Response to UV
2000
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Activator protein 1 (AP-1)– and nuclear factor κB (NF-κB)–dependent transcriptional events in carcinogenesis
2000
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins
2000
Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion
1988
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
2009 Standout
Epidermodysplasia Verruciformis: Immunological and Clinical Aspects
1994
Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV‐1 by deletion of the env amino‐terminal signal sequence
1990 StandoutNobel
Dynamic control over cell adhesive properties using molecular-based surface engineering strategies
2009 StandoutNobel
AP-1 as a regulator of cell life and death
2002 Standout
Involvement of the Akt/mTOR pathway on EGF‐induced cell transformation
2003
MAP kinase signalling pathways in cancer
2007 Standout
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1α ubiquitination and degradation
2007 StandoutNobel
Antigen recognition by helper T cells elicits a sequence of distinct changes of their shape and intracellular calcium
1994
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Evaluation of Cancer-Preventive Activity and Structure–Activity Relationships of 3-Demethylubiquinone Q2, Isolated from the Ascidian Aplidium glabrum, and its Synthetic Analogs
2005
CD4 T‐cell epitopes of human α B‐crystallin
2004
Bone morphogenetic proteins: multifunctional regulators of vertebrate development.
1996 Standout
The pathobiology of mucositis
2004 Standout
The promise of retinoids to fight against cancer
2001
Differential Regulation of the AP-1 Family Members by UV Irradiation In Vitro and In Vivo
1998
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Pathology and new players in the pathogenesis of brain edema
2009
Oxidative stress mediates cell surface expression of SS-A/Ro antigen on keratinocytes
2002 StandoutNobel
The functional contrariety of JNK
2007
Function and regulation of AP-1 subunits in skin physiology and pathology
2001
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
1994 Standout
Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes
1999
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
2009 Standout
Resveratrol Inhibits Phorbol Ester and UV-Induced Activator Protein 1 Activation by Interfering with Mitogen-Activated Protein Kinase Pathways
2001
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Role of Reactive Oxygen Species and p53 in Chromium(VI)-induced Apoptosis
1999 Standout
Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway
2002
AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers
2002
Understanding biophysicochemical interactions at the nano–bio interface
2009 Standout
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype
1999
The Biochemistry and Cell Biology of Antigen Processing and Presentation
1993
Capsaicin suppresses phorbol ester-induced activation of NF-κB/Rel and AP-1 transcription factors in mouse epidermis
2001
Molecular mechanisms of mTOR-mediated translational control
2009 Standout
Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
1999 StandoutNobel
Parkinson's Disease
2003 Standout
The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects
2002
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
The anticancer effects of actinoporin RTX-A from the sea anemone Heteractis crispa (=Radianthus macrodactylus)
2009
Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation
2000 Standout
Mechanisms of inhibition of the Ras‐MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (‐)‐epigallocatechin‐3‐gallate and theaflavin‐3,3′‐digallate 1
2001
Pathogenesis of Group A Streptococcal Infections
2000 Standout
Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice.
2001
Requirement for Phosphatidylinositol 3-Kinase in Epidermal Growth Factor-Induced AP-1 Transactivation and Transformation in JB6 P+ Cells
1996
Inhibition of Ultraviolet B-Induced AP-1 Activation by Theaflavins From Black Tea
2000
The Nuclear Factor YY1 Suppresses the Human Gamma Interferon Promoter through Two Mechanisms: Inhibition of AP1 Binding and Activation of a Silencer Element
1996
Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved.
1999
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid
1997
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
1999
Proapoptotic and Anticarcinogenic Activities of Leviusculoside G from the Starfish Henricia leviuscula and Probable Molecular Mechanism
2008
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol.
2001
Interferon-Beta Prevents Cytokine-Induced Neutrophil Infiltration and Attenuates Blood–Brain Barrier Disruption
2003
Structure of a Complex of the Human α/β T Cell Receptor (TCR) HA1.7, Influenza Hemagglutinin Peptide, and Major Histocompatibility Complex Class II Molecule, HLA-DR4 (DRA0101 and DRB10401)
2002
Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells
1998
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Transcriptional control of human p53-regulated genes
2008 Standout
RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation.
1995
The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation
2002
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
2005 Standout
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
1995 StandoutNobel
Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion
1999
The Ecology of Arsenic
2003 StandoutScience
A Novel Function of the MA-3 Domains in Transformation and Translation Suppressor Pdcd4 Is Essential for Its Binding to Eukaryotic Translation Initiation Factor 4A
2004
Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A
1996
Altered peptidase and viral-specific T cell response in LMP2 mutant mice
1994 StandoutNobel
Dactylone Inhibits Epidermal Growth Factor–Induced Transformation and Phenotype Expression of Human Cancer Cells and Induces G1-S Arrest and Apoptosis
2007
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases
2003 Standout
SAG/ROC2/Rbx2 Is a Novel Activator Protein-1 Target that Promotes c-Jun Degradation and Inhibits 12-O-Tetradecanoylphorbol-13-Acetate–Induced Neoplastic Transformation
2007
Differentiation modulates the balance of positive and negative Jun/AP-1 DNA binding activities to regulate cellular proliferative potential: different effects in nontransformed and transformed cells.
1996
Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice
2009 Standout
Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase.
2001
Involvement of Ras/Raf/AP-1 in BMP-4 signaling during Xenopus embryonic development.
1996
The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions.
1996
Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate.
2002
AP-1 blockade inhibits the growth of normal and malignant breast cells
2001
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
2008 Standout

Works of R Watts being referenced

Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2
1989
PROGRESSIVE ELEVATION OF AP-1 ACTIVITY DURING PRENEOPLASTIC-TO-NEOPLASTIC PROGRESSION AS MODELED IN MOUSE JB6 CELL VARIANTS
1995
Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
1988
The role of polymorphic HLA-DR beta chain residues in presentation of viral antigens to T cells.
1990
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
1994
Rankless by CCL
2026